NCT00000307
Completed
Phase 2
Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients
DrugsNaltrexone
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Alcohol-Related Disorders
- Sponsor
- National Institute on Drug Abuse (NIDA)
- Locations
- 1
- Primary Endpoint
- Verified abstinence from cocaine
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Verified abstinence from cocaine
Time Frame: over the 12 weeks of study
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 2
Naltrexone in Treatment of Cocaine Dependence - 5Cocaine-Related DisordersNCT00015080National Institute on Drug Abuse (NIDA)
Completed
Phase 2
Combined Treatment for Cocaine-Alcohol Dependence - 1Alcohol DependenceCocaine DependenceNCT00218569The University of Texas Health Science Center, Houston87
Completed
Phase 2
Combination of Disulfiram Plus Naltrexone to Treat Both Cocaine- and Alcohol-dependent Individuals - 1Alcohol-Related DisordersAlcoholismCocaine-Related DisordersNCT00142844University of Pennsylvania208
Completed
Phase 4
Targeted Naltrexone for Problem DrinkersAlcoholismAlcohol DrinkingAlcohol DependenceNCT00369408UConn Health163
Completed
Phase 2
Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and DrinkingAlcohol DependenceNCT00183222Medical University of South Carolina160